| 1 | Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis | Coautor: Kershenobich-Stalnikowitz D., Sanz-Garcia C., Nevzorova Y.A., Martínez-Naves E., et al. | 2023 | GASTROENTEROLOGIA Y HEPATOLOGIA | WoS-id: 000995945800001
Scopus-id: 2-s2.0-85133259613
| 1 | 1 |
| 2 | NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study | Coautor: Kershenobich-Stalnikowitz D., Moctezuma-Velázquez P., Miranda-Zazueta G., Ortiz-Brizuela E., et al. | 2022 | INTERN EMERG MED | WoS-id: 000753233000001
Scopus-id: 2-s2.0-85124551300
| 14 | 14 |
| 3 | Large scale screening for SARS-CoV-2 among healthcare workers: Prevalence and risk factors for asymptomatic/pauci-symptomatic carriers, with emphasis on PPE use | Coautor: Kershenobich-Stalnikowitz D., Rajme-Lopez S., Gonzalez-Lara M.F., Ortiz-Brizuela E., et al. | 2022 | INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | WoS-id: 000767342800001
Scopus-id: 2-s2.0-85101552380
| 4 | 1 |
| 4 | Galectin-3 is overexpressed in advanced cirrhosis and predicts post-liver transplant infectious complications | Coautor: Kershenobich D., Cervantes-Alvarez E., Limon-de la Rosa N., Vilatoba M., et al. | 2022 | LIVER INTERNATIONAL | WoS-id: 000809704000001
Scopus-id: 2-s2.0-85131723009
| 15 | 16 |
| 5 | Liver transplantation is beneficial regardless of cirrhosis stage or acute-on-chronic liver failure grade: A single-center experience | Coautor: Kershenobich, David, Cervantes-Alvarez, Eduardo, Vilatoba, Mario, Limon-de la Rosa, Nathaly, et al. | 2022 | WORLD JOURNAL OF GASTROENTEROLOGY | WoS-id: 000885969400008
Scopus-id: 2-s2.0-85141508539
| 7 | 8 |
| 6 | Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018 | Coautor: Kershenobich D., Carnalla M., Barrientos-Gutiérrez T., Vidaña-Perez D., et al. | 2022 | LANCET REGIONAL HEALTH-AMERICAS | WoS-id: 000904623700008
Scopus-id: 2-s2.0-85126935275
| 9 | 10 |
| 7 | Erratum: In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation (PLoS ONE 16(2) (e0245772) DOI: 10.1371/journal.pone.0245772) | Coautor: Kershenobich-Stalnikowitz D., Olivas-Martínez A., Cárdenas-Fragoso J.L., Jiménez J.V., et al. | 2022 | PLOS ONE | WoS-id: 001044877900006
Scopus-id: 2-s2.0-85130431737
| 0 | 1 |
| 8 | Probability of hospitalisation and death among COVID-19 patients with comorbidity during outbreaks occurring in Mexico City | Coautor: Kershenobich D., Sifuentes-Osornio J., Angulo-Guerrero O., de Anda-Jáuregui G., et al. | 2022 | JOURNAL OF GLOBAL HEALTH | WoS-id: 001123148500001
Scopus-id: 2-s2.0-85141892171
| 6 | 8 |
| 9 | Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients With COVID-19-Induced Acute Respiratory Distress Syndrome | Coautor: Kershenobich D., Jimenez J.V., Olivas-Martinez A., Rios-Olais F.A., et al. | 2022 | Critical Care Explorations | WoS-id: 001275978700010
Scopus-id: 2-s2.0-85138110302
| 13 | 14 |
| 10 | Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity | 2ᵒ autor: Kershenobich Stalnikowitz D., Wolpert Barraza E., Guerrero Guerrero J.E., de la Torre Rosas A. | 2022 | Clinical Liver Disease | Scopus-id: 2-s2.0-85112106691
| 0 | 2 |
| 11 | The case for simplifying and using absolute targets for viral hepatitis elimination goals | Coautor: KERSHENOBICH, DAVID, Razavi, Homie, Blach, Sarah, Razavi-Shearers, Devin, et al. | 2021 | JOURNAL OF VIRAL HEPATITIS | WoS-id: 000584509000001
Scopus-id: 2-s2.0-85098674981
| 31 | 31 |
| 12 | In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation | Coautor: Kershenobich-Stalnikowitz D., Olivas-Martínez A., Cárdenas-Fragoso J.L., Jiménez J.V., et al. | 2021 | PLOS ONE | WoS-id: 000616739700022
Scopus-id: 2-s2.0-85100668173
| 90 | 93 |
| 13 | Production and activity of matrix metalloproteinases during liver fibrosis progression of chronic hepatitis C patients | Coautor: KERSHENOBICH, DAVID, Martinez-Castillo, Moises, Hernandez-Barragan, Abigail, Flores-Vasconcelos, Ivonne, et al. | 2021 | World Journal of Hepatology | WoS-id: 000627885900004
Scopus-id: 2-s2.0-85102139477
| 12 | 15 |
| 14 | Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City | Coautor: Kershenobich-Stalnikowitz D., Lozano-Cruz O.A., Jiménez J.V., Olivas-Martinez A., et al. | 2021 | FRONTIERS IN PHARMACOLOGY | WoS-id: 000662241400001
Scopus-id: 2-s2.0-85108205902
| 2 | 3 |
| 15 | Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City | Coautor: Kershenobich-Stalnikowitz D., Hernández-Jiménez S., Garciá-Ulloa A.C., Anaya P., et al. | 2021 | BMJ OPEN DIABETES RESEARCH & CARE | WoS-id: 000688257900003
Scopus-id: 2-s2.0-85108634618
| 6 | 6 |
| 16 | Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B | Coautor: Kershenobich D., Higuera-de-la-Tijera F., Castro-Narro G.E., Velarde-Ruiz Velasco J.A., et al. | 2021 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | WoS-id: 000703173400011
Scopus-id: 2-s2.0-85112194524
| 6 | 7 |
| 17 | The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City | Coautor: KERSHENOBICH, DAVID, Cedro-Tanda, Alberto, Gomez-Romero, Laura, Alcaraz, Nicolas, et al. | 2021 | Viruses-Basel | WoS-id: 000725216500001
Scopus-id: 2-s2.0-85118415313
| 26 | 26 |
| 18 | Prevalence and predictors of elevated liver enzyme levels in Mexico: The Mexican National Health and Nutrition Survey, 2016 | Coautor: Kershenobich D., Denova-Gutiérrez E., Lara-Castor L., Hernández-Alcaraz C., et al. | 2021 | Annals Of Hepatology | WoS-id: 000758257300005
Scopus-id: 2-s2.0-85121003932
| 9 | 7 |
| 19 | Plasma ccl16 chemokine secretion and expression in liver tissue of patients with autoimmune hepatitis: A pilot study | Coautor: Kershenobich-Stalnikowitz D., Romano-Munive A.F., Moctezuma-Velázquez C., Keil-Ríos D., et al. | 2021 | Acta Gastroenterologica Latinoamericana | Scopus-id: 2-s2.0-85116604438
| 0 | 0 |
| 20 | Eliminating Hepatitis C in Mexico: A Primary Health Care Approach | 2ᵒ autor: Kershenobich D., De la Torre Rosas A., Svarch A.E., López-Gatell H. | 2021 | Clinical Liver Disease | Scopus-id: 2-s2.0-85118984304
| 0 | 8 |
| 21 | Translation of gastric disease progression at gene level expression | Coautor: David Kershenobich-Stalnikowitz, Euridice Morales-Guerrero, Stephanie, Ivette Rivas-Ortiz, Claudia, Ponce de Leon-Rosales, Sergio, et al. | 2020 | JOURNAL OF CANCER | WoS-id: 000498028200025
Scopus-id: 2-s2.0-85077725349
| 6 | 7 |
| 22 | Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression | Coautor: KERSHENOBICH, DAVID, Martinez-Castillo, Moises, Rosique-Oramas, Dorothy, Medina-Avila, Zaira, et al. | 2020 | MOLECULAR AND CELLULAR BIOCHEMISTRY | WoS-id: 000534884800007
Scopus-id: 2-s2.0-85083482218
| 16 | 17 |
| 23 | The Mexican consensus on alcoholic hepatitis | Coautor: Kershenobich-Stalnikowitz D., Velarde-Ruiz Velasco J.A., Higuera-de la Tijera M.F., Castro-Narro G.E., et al. | 2020 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | WoS-id: 000553039700015
Scopus-id: 2-s2.0-85086149783
| 4 | 4 |
| 24 | Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study | Coautor: Kershenobich D., Cantoral A., Montoya A., Luna-Villa L., et al. | 2020 | BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | WoS-id: 000559243400006
Scopus-id: 2-s2.0-85083051819
| 10 | 12 |
| 25 | Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients | Coautor: KERSHENOBICH, DAVID, Lizardo-Thiebaud, Maria J., Cervantes-Alvarez, Eduardo, Limon-de la Rosa, Nathaly, et al. | 2020 | SEMINARS IN LIVER DISEASE | WoS-id: 000565893900010
Scopus-id: 2-s2.0-85090509506
| 21 | 24 |
| 26 | Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes | Coautor: Kershenobich-Stalnikowitz D., Graue-Hernandez E.O., Rivera-De-La-Parra D., Hernandez-Jimenez S., et al. | 2020 | Bmj Open Ophthalmology | WoS-id: 000573920500001
Scopus-id: 2-s2.0-85082032527
| 23 | 25 |
| 27 | Production of insulin-like growth factor-binding proteins during the development of hepatic fibrosis due to chronic hepatitis C | Coautor: Kershenobich D., Rosique-Oramas D., Martínez-Castillo M., Raya A., et al. | 2020 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | WoS-id: 000592027500004
Scopus-id: 2-s2.0-85075393234
| 3 | 4 |
| 28 | Submuestra para el análisis de enfermedades crónicas con biomarcadores, Encuesta Nacional de Salud y Nutrición 2016 | Coautor: Kershenobich-Stalnikowitz D., Hernández-Alcaraz C., Shamah-Levy T., Romero-Martínez M., et al. | 2020 | SALUD PUBLICA DE MEXICO | WoS-id: 000597326100016
Scopus-id: 2-s2.0-85092684539
| 5 | 5 |
| 29 | DILEMMAS OF A PHYSICIAN IN TIMES OF COVID-19 | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2020 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000613899200001
Scopus-id: 2-s2.0-85087100259
| 1 | 0 |
| 30 | CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY | Coautor: Kershenobich-Stalnikowitz D., Ortiz-Brizuela E., Villanueva-Reza M., González-Lara M.F., et al. | 2020 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000613899200008
Scopus-id: 2-s2.0-85087100323
| 95 | 77 |
| 31 | Erratum: CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY (Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion (2020) 72 3 (165-177)) | Coautor: Kershenobich-Stalnikowitz D., Ortiz-Brizuela E., Villanueva-Reza M., González-Lara M.F., et al. | 2020 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000613899300010
Scopus-id: 2-s2.0-85093705589
| 0 | 9 |
| 32 | Development and Validation of a Software Linked to an Internet Portal That Facilitates the Medical Treatment and Empowerment of Patients with Type 2 Diabetes, Interaction with Medical Personnel, and the Generation of a Real-Time Registry | Coautor: Kershenobich-Stalnikowitz D., García-Ulloa A.C., Almeda-Valdes P., Aguilar-Salinas C.A., et al. | 2020 | Journal of diabetes science and technology | WoS-id: 000904092200031
Scopus-id: 2-s2.0-85089572412
| 0 | 0 |
| 33 | The Mexican consensus on nonalcoholic fatty liver disease | Coautor: Kershenobich-Stalnikowitz D., Bernal-Reyes R., Castro-Narro G., Malé-Velázquez R., et al. | 2019 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | WoS-id: 000458659700009
Scopus-id: 2-s2.0-85060727346
| 37 | 46 |
| 34 | Long-term effectiveness of a type 2 diabetes comprehensive care program. The CAIPaDi model | Coautor: Kershenobich-Stalnikowitz, David, Hernandez-Jimenez, Sergio, Cristina Garcia-Ulloa, Ana, Yaxmehen Bello-Chavolla, Omar, et al. | 2019 | DIABETES RESEARCH AND CLINICAL PRACTICE | WoS-id: 000469020000016
Scopus-id: 2-s2.0-85064277479
| 32 | 31 |
| 35 | Acciones prioritarias para un programa nacional de detección, tratamiento y seguimiento de pacientes con hepatitis C | Coautor: Kershenobich-Stalnikowitz D., Wolpert-Barraza E., Muñoz-Hernández O., Coalicion para el estudio de la hepatitis C en Mexico., et al. | 2019 | SALUD PUBLICA DE MEXICO | WoS-id: 000472177900019
Scopus-id: 2-s2.0-85064533157
| 3 | 4 |
| 36 | Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3 Expression in Peripheral Blood CD8 T Cells | Coautor: Kershenobich, David, Martín-Manzo M.V., Lara, Carlos, Vargas-de-Leon, Cruz, et al. | 2019 | PATHOLOGY & ONCOLOGY RESEARCH | WoS-id: 000475558500045
Scopus-id: 2-s2.0-85061691651
| 21 | 19 |
| 37 | Prolactin induces il-2 associated trail expression on natural killer cells from chronic hepatitis c patients in vivo and in vitro | Coautor: Kershenobich D., Medel M.L.H., Reyes G.G., Porras L.M., et al. | 2019 | ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS | WoS-id: 000489743500008
Scopus-id: 2-s2.0-85073673343
| 3 | 3 |
| 38 | Young adult binge drinkers have immunophenotypical disarrangements in peripheral natural killer cells | Coautor: Kershenobich D., Pérez-García A., Arroyo-Valerio A.G., Bustos-Esquivel M.A., et al. | 2019 | Alcohol | WoS-id: 000505855500010
Scopus-id: 2-s2.0-85074563595
| 1 | 0 |
| 39 | Young adult binge drinkers have immunophenotypic changes in peripheral polymorphonuclear cells and monocytes | Coautor: Kershenobich D., Pérez-García A., Arroyo-Valerio A.G., Zaldivar-Fujigaki J.L., et al. | 2018 | AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE | WoS-id: 000427952700015
Scopus-id: 2-s2.0-85019021152
| 3 | 4 |
| 40 | Heading toward the elimination of hepatitis c virus | 1ᵉʳ autor: Kershenobich D., Torre-Delgadillo A., Aguilar-Valenzuela L.M. | 2018 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000430528600003
Scopus-id: 2-s2.0-85046692172
| 4 | 2 |
| 41 | Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study | Coautor: Kershenobich D., Razavi-Shearer D., Gamkrelidze I., Nguyen M.H., et al. | 2018 | LANCET GASTROENTEROLOGY & HEPATOLOGY | WoS-id: 000436553600019
Scopus-id: 2-s2.0-85044540918
| 1254 | 1486 |
| 42 | Presentación | 1ᵉʳ autor: Kershenobich D., Shamah-Levy T. | 2018 | SALUD PUBLICA DE MEXICO | WoS-id: 000442172800002
Scopus-id: 2-s2.0-85046494709
| 1 | 1 |
| 43 | A front-of-pack labelling system for food and beverages for Mexico: a strategy of healthy decision-making | Coautor: Kershenobich D., Kaufer-Horwitz M., Tolentino-Mayo L., Jáuregui A., et al. | 2018 | SALUD PUBLICA DE MEXICO | WoS-id: 000442199300024
Scopus-id: 2-s2.0-85049210396
| 15 | 30 |
| 44 | Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin | Coautor: Kershenobich D., Barquera S., Schillinger D., Aguilar-Salinas C.A., et al. | 2018 | GLOBALIZATION AND HEALTH | WoS-id: 000442802400001
Scopus-id: 2-s2.0-85052076568
| 9 | 11 |
| 45 | Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico | Coautor: Kershenobich-Stalnikowitz D., Marfil-Garza B.A., Belaunzarán-Zamudio P.F., Gulias-Herrero A., et al. | 2018 | PLOS ONE | WoS-id: 000449512300090
Scopus-id: 2-s2.0-85056395067
| 57 | 66 |
| 46 | Correction: Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico (PLoS ONE (2018) 13: 11(e0207203) Doi : 10.1371/journal.pone.0207203) | Coautor: Kershenobich-Stalnikowitz D., Marfil-Garza B.A., Belaunzarán-Zamudio P.F., Gulias-Herrero A., et al. | 2018 | PLOS ONE | WoS-id: 000454149400083
Scopus-id: 2-s2.0-85058917122
| 0 | 1 |
| 47 | NutriNet-Salud Mexico. Prospective study online: 2018-2028. Relationship between nutrition and health and determinants of dietary habits and nutritional status | Coautor: Kershenobich, D., Armando Barriguete-Melendez, Jorge, Hercberg, Serge, Galan, Pilar, et al. | 2018 | CIRUGIA Y CIRUJANOS | WoS-id: 000510014400002
Scopus-id: 2-s2.0-85064322251
| 0 | 1 |
| 48 | The Mexican consensus on the treatment of hepatitis C | Coautor: Kershenobich-Stalnikowitz D., Aiza-Haddad I., Ballesteros-Amozurrutia A., Borjas-Almaguer O.D., et al. | 2018 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-85047343054
| 0 | 9 |
| 49 | Electrolyte and Acid?Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach | Coautor: Kershenobich, D., Jiménez, J.V., Carrillo-Pérez, D.L., Rosado-Canto, R., et al. | 2017 | DIGESTIVE DISEASES AND SCIENCES | WoS-id: 000405522400006
Scopus-id: 2-s2.0-85019170354
| 37 | 43 |
| 50 | NutriNet Health Mexico France 2017-2027: Prospective Internet Study. Prevention Digital Network | Coautor: Kershenobich, D., Barriguete, M. J. A., Hercberg, S., Galan, P., et al. | 2017 | E-Memoires De L Academie Nationale De Chirurgie | WoS-id: 000405986800007
| 0 | 0 |
| 51 | High HPgV replication is associated with improved surrogate markers of HIV progression | Coautor: Kershenobich, David, Horemheb-Rubio, Gibran, Ramos-Cervantes, Pilar, Arroyo-Figueroa, Hugo, et al. | 2017 | PLOS ONE | WoS-id: 000410859200052
Scopus-id: 2-s2.0-85029516804
| 18 | 18 |
| 52 | Evaluation of liver fibrosis using Raman spectroscopy and infrared thermography: A pilot study | Coautor: Kershenobich D., Ramírez-Elías M.G., Kolosovas-Machuca E.S., Guzmán C., et al. | 2017 | PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY | WoS-id: 000412252100045
Scopus-id: 2-s2.0-85026748049
| 13 | 14 |
| 53 | Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study | Coautor: Kershenobich, D., Blach, S., Zeuzem, S., Manns, M., et al. | 2017 | LANCET GASTROENTEROLOGY & HEPATOLOGY | WoS-id: 000426979400014
Scopus-id: 2-s2.0-85012877259
| 1506 | 1732 |
| 54 | The expression of PNPLA3 polymorphism could be the key for severe liver disease in NAFLD in hispanic population | Coautor: Kershenobich D., Martínez L.A., Larrieta E., Calva J.J., et al. | 2017 | Annals Of Hepatology | Scopus-id: 2-s2.0-85031925776
| 0 | 57 |
| 55 | Fibrosis evaluation of animal liver tissue by thermal conduction | Coautor: Kershenobich D., Alemán-García N., Pérez-García A., Sánchez-Melecio J., et al. | 2017 | IFMBE Proceedings | Scopus-id: 2-s2.0-85018391333
| 0 | 1 |
| 56 | Lactancia materna en México | 1ᵉʳ autor y autor de correspondencia: Kershenobich, D. | 2017 | SALUD PUBLICA DE MEXICO | Scopus-id: 2-s2.0-85020012928
| 0 | 5 |
| 57 | Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting | Coautor: Kershenobich, D., Chirino-Sprung, R.A., Dehesa, M., Wolpert, E., et al. | 2016 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000385468900007
Scopus-id: 2-s2.0-85024402676
| 5 | 7 |
| 58 | Behavior of Oxidative Stress Markers in Alcoholic Liver Cirrhosis Patients | Coautor: Kershenobich, David, Galicia-Moreno, Marina, Rosique-Oramas, Dorothy, Medina-Avila, Zaira, et al. | 2016 | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | WoS-id: 000390782300001
Scopus-id: 2-s2.0-85008953597
| 36 | 44 |
| 59 | Los criterios de elegibilidad actuales del Seguro Popular para recibir tratamiento para el virus de la hepatitis C | Coautor: Kershenobich-Stalnikowitz D., Moctezuma-Velázquez C., Sánchez-Ávila J.F., García-Juárez I., et al. | 2016 | SALUD PUBLICA DE MEXICO | WoS-id: 000391646000006
Scopus-id: 2-s2.0-85058595407
| 0 | 0 |
| 60 | Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2 | Coautor: Kershenobich D., Saraswat V., Norris S., De Knegt R.J., et al. | 2015 | JOURNAL OF VIRAL HEPATITIS | WoS-id: 000347310500002
Scopus-id: 2-s2.0-84920274258
| 85 | 89 |
| 61 | The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - Volume 2 | Coautor: Kershenobich D., Hatzakis A., Chulanov V., Gadano A.C., et al. | 2015 | JOURNAL OF VIRAL HEPATITIS | WoS-id: 000347310500003
Scopus-id: 2-s2.0-84920270905
| 110 | 115 |
| 62 | Strategies to manage hepatitis C virus (HCV) infection disease burden - Volume 2 | 2ᵒ autor: Kershenobich D., Gane E., Seguin-Devaux C., Kristian P., et al. | 2015 | JOURNAL OF VIRAL HEPATITIS | WoS-id: 000347310500004
Scopus-id: 2-s2.0-84920279600
| 56 | 55 |
| 63 | Regulation on palliative care and assisted suicide [Regulación de los cuidados paliativos y muerte asistida] | Coautor: Kershenobich-Stalnikowitz D., Cossío-Díaz J.R., González-Salas J.F.F., Goslinga-Remírez L., et al. | 2015 | GACETA MEDICA DE MEXICO | WoS-id: 000351422100016
Scopus-id: 2-s2.0-84929519459
| 3 | 3 |
| 64 | Alterations in Activation, Cytotoxic Capacity and Trafficking Profile of Peripheral CD8 T Cells in Young Adult Binge Drinkers | Coautor: Kershenobich D., Fujigaki, JLZ, Valerio, AGA, Alvarenga, JCL, et al. | 2015 | PLOS ONE | WoS-id: 000358158900044
Scopus-id: 2-s2.0-85018935997
| 9 | 11 |
| 65 | Rapid prototyping of integrated biochips for on-demand 3D cell culture | Coautor: Kershenobich-Stalnikowitz D., Hautefeuille M., Stern-Forgach C., López-Aparicio J., et al. | 2015 | Progress in Biomedical Optics and Imaging | WoS-id: 000360229400021
Scopus-id: 2-s2.0-84939220182
| 0 | 0 |
| 66 | Editorial | 1ᵉʳ autor: Kershenobich D., Ruiz-Palacios G., Ulloa-Aguirre A., Arrieta Ó., et al. | 2015 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000368650400001
Scopus-id: 2-s2.0-85040609480
| 0 | 0 |
| 67 | Hepatitis C screening in the general population | Coautor: Kershenobich D., Corona-Lau C., Muñoz L., Wolpert E., et al. | 2015 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000368650600005
Scopus-id: 2-s2.0-84948170049
| 5 | 6 |
| 68 | Acetaldehyde targets superoxide dismutase 2 in liver cancer cells inducing transient enzyme impairment and a rapid transcriptional recovery | Coautor: Kershenobich D., Clavijo-Cornejo D., Gutiérrez-Carrera M., Palestino-Domínguez M., et al. | 2014 | FOOD AND CHEMICAL TOXICOLOGY | WoS-id: 000338817900014
Scopus-id: 2-s2.0-84899704433
| 14 | 15 |
| 69 | Unfolded protein response activation in cataracts | Coautor: Stalnikowitz, DDK, Torres-Bernal B.E., Torres-Bernal L.F., Gutiérrez-Campos R.R., et al. | 2014 | JOURNAL OF CATARACT AND REFRACTIVE SURGERY | WoS-id: 000342885000019
Scopus-id: 2-s2.0-84925884262
| 2 | 7 |
| 70 | [Vicissitudes of hepatitis C in México] [Vicisitudes de la hepatitis C en México] | 1ᵉʳ autor: Kershenobich D., Aguilar-Valenzuela L.M., Muñoz L. | 2014 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000345887200002
Scopus-id: 2-s2.0-84925355969
| 1 | 0 |
| 71 | CARBONYLATED PROTEINS AND GLUTATHIONE LEVELS AS IMPORTANT OXIDATIVE BIOMARKERS IN ALCOHOLIC LIVER DISEASE | Coautor: Kershenobich, D., Galicia, M., Rosique Oramas, D., Alvarez Torres, T., et al. | 2014 | JOURNAL OF HEPATOLOGY | WoS-id: 000362828600449
| 0 | 0 |
| 72 | Innovative models for the empowerment of patients with type 2 diabetes: The CAIPaDi program | Coautor: Kershenobich-Stalnikowitz D., Hernández-Jiménez S., García-Ulloa C., Mehta R., et al. | 2014 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | Scopus-id: 2-s2.0-84919762491
| 0 | 28 |
| 73 | Vicissitudes of hepatitis C in Mexico [Vicisitudes de la hepatitis C en México] | 1ᵉʳ autor: Kershenobich D., Aguilar-Valenzuela L.M., Muñoz L. | 2014 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | Scopus-id: 2-s2.0-84920168130
| 0 | 1 |
| 74 | Over-expression of human cystatin C in pterygium versus healthy conjunctiva | Coautor: Stalnikowitz, DK, Barba-Gallardo L.F., Ventura-Juárez J., Gutierez-Campos, R, et al. | 2013 | BMC OPHTHALMOLOGY | WoS-id: 000316256700001
Scopus-id: 2-s2.0-84874239454
| 5 | 5 |
| 75 | Hacia la cobertura universal en salud: Protección social para todos en México | Coautor: Kershenobich D., Knaul F.M., González-Pier E., Gómez-Dantés O., et al. | 2013 | SALUD PUBLICA DE MEXICO | WoS-id: 000316582600013
Scopus-id: 2-s2.0-84877929546
| 27 | 31 |
| 76 | Liver exhibits thermal variations according to the stage of fibrosis progression: A novel use of modulated-differential scanning calorimetry for research in hepatology | Coautor: Kershenobich D., Escobedo G., Arjona-Román J.L., Meléndez-Pérez R., et al. | 2013 | HEPATOLOGY RESEARCH | WoS-id: 000320936800011
Scopus-id: 2-s2.0-84879701189
| 7 | 7 |
| 77 | THE SPANISH-LATIN AMERICAN DILI NETWORK: PRELIMINARY RESULTS FROM A COLLABORATIVE STRATEGIC INITIATIVE | Coautor: Kershenobich, D, Bessone, F, Hernandez, N, Sanchez, A, et al. | 2013 | JOURNAL OF HEPATOLOGY | WoS-id: 000322983000519
| 3 | 0 |
| 78 | THE LIVER EXHIBITS THERMAL VARIATIONS DEPENDING ON THE FIBROSIS DEGREE: A PROOF OF CONCEPT CONCERNING THE USE OF DIFFERENTIAL SCANNING CALORIMETRY FOR ASSESSING LIVER FIBROSIS | Coautor: Kershenobich, D, Arjona-San Roman, JL, Melendez-Perez, R, Gutierrez-Reyes, G, et al. | 2013 | JOURNAL OF HEPATOLOGY | WoS-id: 000322983001371
| 0 | 0 |
| 79 | Development of medical specialties in Mexico. Department of Health, UNAM, National Academy of Medicine [Desarrollo de las especialidades médicas en México Secretaría de Salud, UNAM, Academia Nacional de Medicina] | Coautor: Kershenobich D., Dolci G.F., Wiechers E.G., Puig P.V., et al. | 2013 | Medicina Interna De México | Scopus-id: 2-s2.0-84877013993
| 0 | 0 |
| 80 | Guideline for interpretation and report of the antibody to hepatitis C virus [Guíade interpretación y reporte del anticuerpo a hepatitis C] | Coautor: Kershenobich D., Contreras A.M., Ochoa-Jiménez R.J., Granados-García V., et al. | 2012 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000209020400010
Scopus-id: 2-s2.0-84875850874
| 3 | 3 |
| 81 | Building a Spanish-Latin American network on drug induced liver injury: much to get from a joint collaborative initiative | Coautor: Kershenobich D., Bessone F., Hernandez N., Dávalos M., et al. | 2012 | Annals Of Hepatology | WoS-id: 000305717600014
Scopus-id: 2-s2.0-84862016967
| 14 | 15 |
| 82 | Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response | Coautor: Kershenobich D., Gellad Z.F., Muir A.J., McHutchison J.G., et al. | 2012 | VALUE IN HEALTH | WoS-id: 000309109800014
Scopus-id: 2-s2.0-84866412445
| 5 | 5 |
| 83 | The quest for universal health coverage: achieving social protection for all in Mexico | Coautor: Kershenobich D., Knaul F.M., González-Pier E., Gómez-Dantés O., et al. | 2012 | Lancet | WoS-id: 000309817500033
Scopus-id: 2-s2.0-84867132803
| 336 | 368 |
| 84 | In vivo assessment of liver fibrosis using diffuse reflectance and fluorescence spectroscopy: A proof of concept | Coautor: Kershenobich D., Fabila D., de la Rosa J.M., Stolik S., et al. | 2012 | PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY | WoS-id: 000312523700015
Scopus-id: 2-s2.0-84870311538
| 21 | 21 |
| 85 | [Hepatic fibrosis] [Fibrosis hepática] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2012 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-84925223521
| 0 | 1 |
| 86 | Applying a system approach to forecast the total hepatitis C virus-infected population size: model validation using US data | 1ᵉʳ autor: Kershenobich D., Razavi H.A., Cooper C.L., Alberti A., et al. | 2011 | LIVER INTERNATIONAL | WoS-id: 000208703500002
Scopus-id: 2-s2.0-79958733325
| 40 | 42 |
| 87 | Trends and projections of hepatitis C virus epidemiology in Latin America | 1ᵉʳ autor: Kershenobich D., Razavi H.A., Sánchez-Avila J.F., Bessone F., et al. | 2011 | LIVER INTERNATIONAL | WoS-id: 000208703500003
Scopus-id: 2-s2.0-79958761330
| 108 | 124 |
| 88 | Management of Alcoholic Liver Disease: An Update | 1ᵉʳ autor: Kershenobich, D, Corona, DL, Kershenovich, R, Gutierrez-Reyes, G | 2011 | ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | WoS-id: 000289896200007
Scopus-id: 2-s2.0-79955463609
| 7 | 10 |
| 89 | [Institutional strengthening and updating of the National Academy of Medicine of Mexico (results and instrumentalization 2010-2012)]. [Fortalecimiento y modernización institucional de la Academia Nacional de Medicina de México (Resultados | 2ᵒ autor: Kershenobich D., Ruiz de Chávez M.H., Mansilla Olivares A., Mancilla Ramírez J., et al. | 2011 | GACETA MEDICA DE MEXICO | WoS-id: 000290117600008
Scopus-id: 2-s2.0-79958783398
| 0 | 0 |
| 90 | CELLULAR SENESCENCE IN A MODEL OF EXPERIMENTAL FIBROSIS: DETERMINATION OF TELOMERE LENGTH RECOVERY AND TELOMERASE REACTIVATION | Coautor: Kershenobich, D, Cequera, A, Senties-Navarro, K, Murga-Garrido, SM, et al. | 2011 | Hepatology | WoS-id: 000295578002316
| 0 | 0 |
| 91 | ASSOCIATION OF GENETIC POLYMORPHISMS OF ADH1B, ALDH2 AND CYP2E1 WITH ALCOHOLISM IN A GROUP OF MEXICAN MESTIZOS | Coautor: Kershenobich, D, Gutierrez-Reyes, G, Rosique, D, Corona-Caloca, LE, et al. | 2011 | Hepatology | WoS-id: 000295578002327
| 1 | 0 |
| 92 | Gene expression patterns in livers of Hispanic patients infected with hepatitis C virus | Coautor: Kershenobich D., Hevezi P.A., Tom E., Wilson K., et al. | 2011 | Autoimmunity | WoS-id: 000295694000002
Scopus-id: 2-s2.0-80053989850
| 5 | 6 |
| 93 | Performance of the international classifications criteria for autoimmune hepatitis diagnosis in Mexican patients | Coautor: Kershenobich, D, Munoz-Espinosa, L, Alarcon, G, Mercado-Moreira, A, et al. | 2011 | Autoimmunity | WoS-id: 000295694000003
Scopus-id: 2-s2.0-80053998101
| 15 | 19 |
| 94 | The impact of genetic variability on liver disease in the Hispanic/Latin-American population | 2ᵒ autor: Kershenobich, D, Lau-Corona, D, Gutierrez-Reyes, G | 2011 | Autoimmunity | WoS-id: 000295694000004
Scopus-id: 2-s2.0-80053982540
| 1 | 1 |
| 95 | An international consensus for medical leadership on alcohol | Coautor: Kershenobich D., Coltart C., Anderson I., Barh B., et al. | 2011 | Lancet | WoS-id: 000295723600014
Scopus-id: 2-s2.0-80053574803
| 10 | 12 |
| 96 | Th2-Associated Alternative Kupffer Cell Activation Promotes Liver Fibrosis without Inducing Local Inflammation | Coautor: Kershenobich D., López-Navarrete G., Ramos-Martínez E., Suárez-Álvarez K., et al. | 2011 | INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | WoS-id: 000298011000006
Scopus-id: 2-s2.0-81255195685
| 34 | 40 |
| 97 | Institutional strengthening and modernization of the National Academy of Medicine of Mexico (Results and instrumentation 2010-2012) [Fortalecimiento y modernización institucional de la Academia Nacional de Medicina de México (Resultados e | 2ᵒ autor: Kershenobich D., de Chávez M.H.R., Olivares A.M., Ramírez J.M., et al. | 2011 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-79960944838
| 0 | 0 |
| 98 | Variant in PNPLA3 is associated with alcoholic liver disease | Coautor: Kershenobich D., Tian C., Stokowski R.P., Ballinger D.G., et al. | 2010 | NATURE GENETICS | WoS-id: 000273055100010
Scopus-id: 2-s2.0-73349111259
| 358 | 392 |
| 99 | Cellular Senescence in Livers from Children with End Stage Liver Disease | Coautor: Kershenobich D., Gutierrez-Reyes G., de Leon, MDG, Varela-Fascinetto G., et al. | 2010 | PLOS ONE | WoS-id: 000276952500009
Scopus-id: 2-s2.0-77956307394
| 37 | 34 |
| 100 | Treatment of HCV infected patients and renal disease | 1ᵉʳ autor y autor de correspondencia: Kershenobich, D | 2010 | Annals Of Hepatology | WoS-id: 000280885700017
Scopus-id: 2-s2.0-79952110536
| 1 | 4 |
| 101 | Proceed With Caution Peginterferon Alpha-2a Versus Peginterferon Alfa-2b in Chronic Hepatitis C. A Systematic Review of Randomized Trials | 1ᵉʳ autor: Kershenobich D., Munoz, L, Malé R., Gaytan J., et al. | 2010 | Hepatology | WoS-id: 000285023700041
Scopus-id: 2-s2.0-78649597268
| 4 | 5 |
| 102 | ANALYSIS OF GENETIC VARIATION IN GENES ASSOCIATED WITH LIVER DISEASE IN THE MEXICAN POPULATION | Coautor: Kershenobich, D, Lau-Corona, D, Fernandez-Lopez, JC, Gutierrez-Reyes, G, et al. | 2010 | Hepatology | WoS-id: 000288775600536
| 0 | 0 |
| 103 | INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1 LEVELS IN CHRONIC HEPATITIS C PATIENTS | Coautor: Kershenobich, D, Guzman, C, Kershenovich, R, Gutierrez-Reyes, G | 2010 | Hepatology | WoS-id: 000288775602534
| 0 | 0 |
| 104 | Latin American association for the study of the liver practice guidelines on Diagnosis, management, and treatment of hepatitis C | Coautor: Kershenobich D., Méndez-Sánchez N., Gadano A., Soza A., et al. | 2010 | Annals Of Hepatology | Scopus-id: 2-s2.0-79955933213
| 0 | 11 |
| 105 | [AASLD plenary sessions. Liver fibrosis in the plenary sessions of the AASLD-AGA 2010] [Plenarias AASLD: La fibrosis en las sesiones plenarias de la AASLD en la reunión de la AGA 2010] | 1ᵉʳ autor y autor de correspondencia: Kershenobich Stalnikowitz D. | 2010 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-84929940595
| 0 | 0 |
| 106 | Applying DNA computing to diagnose-and-interfere hepatic fibrosis | Coautor: Kershenobich D., Farfan B., Strausz R., Mercado G., et al. | 2010 | Proceedings - 2010 6th International Conference On Natural Computation, Icnc 2010 | Scopus-id: 2-s2.0-78149322278
| 0 | 0 |
| 107 | New era of the Gaceta Médica de Mexico [Nueva época de la gaceta médica de méxico] | 2ᵒ autor y autor de correspondencia: Stalnikowitz D.K., Ruiz de Chávez M.H. | 2010 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-79960187590
| 0 | 1 |
| 108 | Effective use of FibroTest to generate decision trees in hepatitis C | Coautor: Kershenobich D., Lau-Corona D., Pineda L.A., Avilés H.H., et al. | 2009 | WORLD JOURNAL OF GASTROENTEROLOGY | WoS-id: 000266786300008
Scopus-id: 2-s2.0-67651152849
| 4 | 8 |
| 109 | Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism | Coautor: Kershenobich D., Valdés-Arzate A., Luna A., Bucio L., et al. | 2009 | FREE RADICAL BIOLOGY AND MEDICINE | WoS-id: 000268386100011
Scopus-id: 2-s2.0-67650034524
| 45 | 50 |
| 110 | Acetaldehyde-induced mitochondrial dysfunction sensitizes hepatocytes to oxidative damage | Coautor: Kershenobich D., Labonne, BEF, Gutiérrez M., Gómez-Quiroz L.E., et al. | 2009 | CELL BIOL TOXICOL | WoS-id: 000271482200007
Scopus-id: 2-s2.0-71349084365
| 65 | 75 |
| 111 | Modification of sleep architecture in an animal model of experimental cirrhosis | Coautor: Kersenobich D., Jiménez-Anguiano A., Díaz-Medina V., Farfán-Labonne B.E., et al. | 2009 | WORLD JOURNAL OF GASTROENTEROLOGY | WoS-id: 000271628000007
Scopus-id: 2-s2.0-73449100126
| 8 | 8 |
| 112 | Deleterious effects of ethanol metabolism are prevented by HGF-induced activation of NFKB and PI3K/AKT signaling pathways | Coautor: Kershenobich, D, Valdes-Arzate, A, Gomez-Quiroz, LE, Ortiz, LB, et al. | 2008 | ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | WoS-id: 000256497201294
| 0 | 0 |
| 113 | Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of I kappa b alpha degradation in liver stellate cells | Coautor: Kershenobich, D, Hernandez, E, Bucio, L, Souza, V, et al. | 2008 | CELL BIOL TOXICOL | WoS-id: 000256909600003
Scopus-id: 2-s2.0-45849140172
| 16 | 19 |
| 114 | THE POSSIBLE ROLE OF PROLACTIN ON INNATE IMMUNE RESPONSE IN CHRONIC HEPATITIS C | Coautor: Kershenobich, D, Gutierrez-Reyes, G, Cordova, J, Farfan-Labonne, BE, et al. | 2008 | Hepatology | WoS-id: 000259757402258
| 1 | 0 |
| 115 | EFFECTIVE USE OF FIBROTEST ATTRIBUTES TO GENERATE DECISION TREES IN HEPATITIS C | Coautor: Kershenobich, D, Lou-Corona, D, Pineda, LA, Aviles, HH, et al. | 2008 | Hepatology | WoS-id: 000259757402466
| 0 | 0 |
| 116 | Efficacy of triple therapy with thymalfasin, peginterferon alpha-2a, and ribavirin for the treatment of hispanic chronic HCV nonresponders | Coautor: Kershenobich D., Poo J.L., Ávila F.S., Samper X.G., et al. | 2008 | Annals Of Hepatology | WoS-id: 000260844900009
Scopus-id: 2-s2.0-56749097120
| 9 | 10 |
| 117 | Preface | 1ᵉʳ autor: Kershenobich D., Martin P. | 2007 | Archives Of Medical Research | WoS-id: 000248194400001
Scopus-id: 2-s2.0-34347259538
| 0 | 0 |
| 118 | Liver Fibrosis and Chronic Viral Hepatitis | Coautor y autor de correspondencia: Kershenobich D., Gutierrez-Reyes G., Gutierrez-Ruiz M.C. | 2007 | Archives Of Medical Research | WoS-id: 000248194400008
Scopus-id: 2-s2.0-34347271294
| 46 | 47 |
| 119 | Prevalence of hepatitis C virus genotypes in Mexican patients. | Coautor y autor de correspondencia: Kershenobich-Stalnikowitz D., Dehesa-Violante M., Bosques-Padilla F. | 2007 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-50949092462
| 0 | 15 |
| 120 | Seroprevalence of hepatitis C among Mexican adults: An emerging public health problem? [Seroprevalencia de la hepatitis C en adultos de México: ¿Un problema de salud pública emergente?] | Coautor: Kershenobich D., Valdespino J.L., Conde-González C.J., Olaiz-Fernández G., et al. | 2007 | SALUD PUBLICA DE MEXICO | Scopus-id: 2-s2.0-34548105926
| 0 | 52 |
| 121 | Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C | Coautor: Kershenobich D., Gutierrez-Reyes G., Lopez-Ortal P., Sixtos S., et al. | 2006 | SCANDINAVIAN JOURNAL OF IMMUNOLOGY | WoS-id: 000238482900009
Scopus-id: 2-s2.0-33745526455
| 30 | 27 |
| 122 | Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis | Coautor: Kershenobich D., Arrieta O., Rodriguez-Diaz J.L., Rosas-Camargo V., et al. | 2006 | CANCER | WoS-id: 000241171300015
Scopus-id: 2-s2.0-33750049023
| 29 | 34 |
| 123 | Association of alcohol-metabolizing genes with alcoholism in a Mexican Indian (Otomi) population | Coautor: Kershenobich D., Montano Loza A.J., Ramirez Iglesias M.T., Perez Diaz I., et al. | 2006 | Alcohol | WoS-id: 000242109400002
Scopus-id: 2-s2.0-33751082978
| 20 | 23 |
| 124 | Indications and contraindications for treatment of hepatitis C virus infections | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2006 | Annals Of Hepatology | Scopus-id: 2-s2.0-33845446357
| 0 | 2 |
| 125 | Ventricular dysfunction in patients with hepatic cirrhosis [Disfunción ventricular en pacientes con cirrosis hepática] | Coautor: Stalnikowitz D.K., Delgadillo A.T., Martínez L.C., Tejeda A.O., et al. | 2006 | Medicina Interna De México | Scopus-id: 2-s2.0-35348950008
| 0 | 0 |
| 126 | Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon a-2b and ribavirin | Coautor: Kershenobich D., Gallegos-Orozco J.F., Loaeza-del Castillo A., Fuentes A.P., et al. | 2005 | LIVER INTERNATIONAL | WoS-id: 000226790700013
Scopus-id: 2-s2.0-20044364746
| 9 | 8 |
| 127 | Differential modulation of interleukin 8 by interleukin 4 and interleukin 10 in HepG2 cells treated with acetaldehyde | Coautor: Kershenobich D., Gómez-Quiroz L.E., Paris R., Lluis J.M., et al. | 2005 | LIVER INTERNATIONAL | WoS-id: 000226790700018
Scopus-id: 2-s2.0-20044377589
| 11 | 12 |
| 128 | Differential effect of interleukin-10 on hepatocyte apoptosis | Coautor: Kershenobich D., Santiago-Lomelí M., Gómez-Quiroz L.E., Ortíz-Ortega V.M., et al. | 2005 | LIFE SCIENCES | WoS-id: 000228127700005
Scopus-id: 2-s2.0-14844343120
| 13 | 13 |
| 129 | Myth and realities of antifibrotic medication [Mitos y realidades de los medicamentos antifibróticos.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2005 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-34248391890
| 0 | 0 |
| 130 | Matching Strategies for Genetic Association Studies in Structured Populations | Coautor: Kershenobich D., Hinds D.A., Stokowski R.P., Patil N., et al. | 2004 | AMERICAN JOURNAL OF HUMAN GENETICS | WoS-id: 000188860000012
Scopus-id: 2-s2.0-0842285687
| 81 | 90 |
| 131 | Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-Week interim results of a pilot study | Coautor: Kershenobich D., Poo J.L., Sánchez-Avila F., García-Samper X., et al. | 2004 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | Scopus-id: 2-s2.0-11144248534
| 0 | 15 |
| 132 | Liver fibrosis and cirrhosis: are they reversible? [Fibrosis y cirrosis hepática: son reversibles?] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2004 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-33748639934
| 0 | 3 |
| 133 | A vision of future treatment of liver diseases [Visió al futuro sobre el tratamiento de las enfermedades hepáticas.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2004 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-33748665469
| 0 | 1 |
| 134 | Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin | Coautor: Kershenobich D., Gallegos-Orozco J.F., Fuentes A.P., Olivera-Martinez M.A., et al. | 2003 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000183185900007
Scopus-id: 2-s2.0-0038724240
| 4 | 4 |
| 135 | Molecular biology in gastroenterology [Biología molecular en gastroenterología] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2003 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000183185900015
Scopus-id: 2-s2.0-0038724237
| 3 | 3 |
| 136 | Interleukin 8 response and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde or lipopolysaccharide | Coautor: Kershenobich D., Gómez-Quiroz L., Bucio L., Souza V., et al. | 2003 | HEPATOLOGY RESEARCH | WoS-id: 000184486700009
Scopus-id: 2-s2.0-17644437965
| 26 | 31 |
| 137 | Liver fibrosis and inflammation. A review. | 1ᵉʳ autor: Kershenobich Stalnikowitz D., Weissbrod A.B. | 2003 | Annals Of Hepatology | Scopus-id: 2-s2.0-3042622803
| 0 | 158 |
| 138 | Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents. [Comparación de dos esquemas diferentes de vacunación contra hepatitis A y B en niños y adolescentes mexicanos.] | Coautor: Kershenobich D., González-Huezo M.S., Sánchez-Avila F., García Mayol M., et al. | 2003 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-2442658277
| 0 | 2 |
| 139 | School-based hepatitis B immunization program in adolescents | 1ᵉʳ autor: Kershenobich D., Concepción Gutierrez-Ruiz M., Olivera-Martínez M.A., Santos I., et al. | 2002 | JOURNAL OF ADOLESCENT HEALTH | WoS-id: 000174851800002
Scopus-id: 2-s2.0-0036129614
| 0 | 0 |
| 140 | TreFoil factor 1 (TFF1/pS2) deficiency activates the unfolded protein response | Coautor: Kershenobich D., Torres L.-F., Karam S.M., Wendling C., et al. | 2002 | MOLECULAR MEDICINE | WoS-id: 000178018100006
Scopus-id: 2-s2.0-0036389657
| 30 | 36 |
| 141 | Pentoxifylline diminished acetaldehyde-induced collagen production in hepatic stellate cells by decreasing interleukin-6 expression | Coautor: Kershenobich D., Hernández E., Correa A., Bucio L., et al. | 2002 | PHARMACOLOGICAL RESEARCH | WoS-id: 000179531800010
Scopus-id: 2-s2.0-0036434480
| 20 | 25 |
| 142 | Emerging concepts in inflammation and fibrosis | Coautor y autor de correspondencia: Kershenobich D., Gutiérrez-Ruíz Ma.C., Robles-Díaz G. | 2002 | Archives Of Medical Research | WoS-id: 000179718200016
Scopus-id: 2-s2.0-0036867293
| 13 | 15 |
| 143 | Mechanisms and cofactors of hepatitis C fibrosis [Mecanismos y cofactores de la fibrosis en la hepatitis C.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 2002 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0141575549
| 0 | 0 |
| 144 | Amebic liver abscess. | 2ᵒ autor y autor de correspondencia: Kershenobich D., Torre A. | 2002 | Annals Of Hepatology | Scopus-id: 2-s2.0-2342624084
| 0 | 8 |
| 145 | Cytokine response and oxidative stress produced by ethanol, acetaldehyde and endotoxin treatment in HepG2 cells. | Coautor: Kershenobich D., Gutierrez-Ruiz M.C., Gomez Quiroz L.E., Hernandez E., et al. | 2001 | ISRAEL MEDICAL ASSOCIATION JOURNAL | WoS-id: 000167509300012
Scopus-id: 2-s2.0-0035259962
| 44 | 49 |
| 146 | Expression of urokinase-type plasminogen activator in an experimental model of hepatocarcinoma | Coautor: Kershenobich D., Nieto-Rodríguez A., Hérnandez-Pando R., Rodríguez-Fragoso L. | 2001 | Toxicology | WoS-id: 000168347100002
Scopus-id: 2-s2.0-0035925626
| 6 | 9 |
| 147 | Hepatic fibrosis [Fibrosis hepática] | 1ᵉʳ autor: Kershenobich D., Gutiérrez-Ruiz Ma.C. | 2001 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000171274800012
Scopus-id: 2-s2.0-0345775701
| 0 | 0 |
| 148 | Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture | Coautor: Kershenobich D., Gutiérrez-Ruiz M.C., Bucio L., Correa A., et al. | 2001 | PHARMACOLOGICAL RESEARCH | WoS-id: 000172447000011
Scopus-id: 2-s2.0-0035198038
| 38 | 49 |
| 149 | Viral dynamics in hepatitis C | 1ᵉʳ autor: Kershenobich D., Henonin C.H. | 2001 | ISRAEL MEDICAL ASSOCIATION JOURNAL | WoS-id: 000172749700009
Scopus-id: 2-s2.0-0035715591
| 1 | 1 |
| 150 | Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde | Coautor: Kershenobich D., Quiroz S.C., Bucio L., Souza V., et al. | 2001 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | WoS-id: 000179451000016
Scopus-id: 2-s2.0-0035698302
| 26 | 29 |
| 151 | Cytokines, growth factors, and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde, and LPS | Coautor: Kershenobich D., Gutiérrez-Ruiz Ma.C., Quiroz S.C., Souza V., et al. | 1999 | Toxicology | WoS-id: 000081213600009
Scopus-id: 2-s2.0-0344603603
| 47 | 48 |
| 152 | Open formulary propossal for a managed care program in Mexico [Propuesta de un formulario abierto para un programa de atencion medica dirigida en Mexico] | Coautor: Kershenobich-Stalnikowitz D., Arredondo-García J.L., Bondani-Guasti A., Burgos-Vargas R., et al. | 1999 | SALUD PUBLICA DE MEXICO | Scopus-id: 2-s2.0-0032998860
| 0 | 1 |
| 153 | Effect of the menstrual cycle in ethanol pharmacokinetics | Coautor: Kershenobich D., Haddad L., Milke P., Zapata L., et al. | 1998 | JOURNAL OF APPLIED TOXICOLOGY | WoS-id: 000072240100002
Scopus-id: 2-s2.0-6844239525
| 18 | 18 |
| 154 | MHC class H sequences of susceptibility and protection in Mexicans with autoimmune hepatitis | Coautor: Kershenobich D., Vázquez-García M.N., Aláez C., Olivo A., et al. | 1998 | JOURNAL OF HEPATOLOGY | WoS-id: 000074229300011
Scopus-id: 2-s2.0-0032092934
| 103 | 111 |
| 155 | Allelic association study between collagen type I (COLIA1 and COLIA2) polymorphisms and alcohol liver disease [Estudio de la asociacion alelica entre los polimorfismos de los genes de colagena tipo I (COLIA1 y COLIA2) y dano hepatico de tipo | Coautor: Kershenobich D., Cruz C., Taba-Shiwa S., Diaz A., et al. | 1998 | SALUD MENTAL | Scopus-id: 2-s2.0-0031686551
| 0 | 1 |
| 156 | Homenaje al doctor Salvador Zubirán (1898-1998). | Coautor: Kershenobich D., Cárdenas-Loaeza M., Guevara-González L., Alarcón-Segovia D., et al. | 1998 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-0032107852
| 0 | 0 |
| 157 | Mexican consensus on Helicobacter pylori [Consenso Mexicano sobre Helicobacter pylori] | Coautor: Kershenobich D., Violante M.D., Diaz G.R., Garcia J.A., et al. | 1997 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0030837102
| 0 | 2 |
| 158 | Antioxidants and human disease: A general introduction | Coautor: Kershenobich D., Halliwell B., Zentella A., Gomez E.O. | 1997 | NUTRITION REVIEWS | WoS-id: A1997WX22300014
Scopus-id: 2-s2.0-0030906870
| 598 | 774 |
| 159 | Helicobacter pylori infection among patients with alcoholic and nonalcoholic cirrhosis | Coautor: Kershenobich D., Schmulson M.J., De Leon G., Kershenovich A., et al. | 1997 | Helicobacter | WoS-id: A1997XU27900008
Scopus-id: 2-s2.0-0031217378
| 14 | 15 |
| 160 | Liver fibrosis [Fibrosis hepática.] | Coautor: Kershenobich D., Taba Shiwa S., Garibay-Nieto N., Angulo-Hernández P., et al. | 1996 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0003431824
| 0 | 1 |
| 161 | Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients | Coautor: Kershenobich D., Diliz H.S., Olivera M.A., Mercado M.A., et al. | 1996 | TRANSPLANTATION PROCEEDINGS | WoS-id: A1996VW99900135
Scopus-id: 2-s2.0-0029809538
| 2 | 2 |
| 162 | Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex | Coautor: Kershenobich D., Moteki S., Leung P.S.C., Rolland Dickson E., et al. | 1996 | Hepatology | WoS-id: A1996TZ78800007
Scopus-id: 2-s2.0-0029929326
| 116 | 126 |
| 163 | The Cullen sign [Signo de Cullen.] | 2ᵒ autor: Kershenobich D., Carmona R., Márquez-Díaz F. | 1996 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0030179278
| 0 | 1 |
| 164 | Primary biliary cirrhosis: clinical features and survival of a Mexican population [Cirrosis biliar primaria: características clínicas y supervivencia en la población Mexicana.] | Coautor: Kershenobich D., Morán S., Rodríguez-Leal G., Marín-López E., et al. | 1996 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0030179817
| 0 | 4 |
| 165 | Hepatitis A: is universal vaccination justified in Mexico? [Hepatitis A: se justifica la vacunación universal en México?] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 1996 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0030253282
| 0 | 1 |
| 166 | Hazardous alcohol consumption among Mexican inpatients. A multicenter study | Coautor: Kershenobich D., Guevara-Arnal L., Zapata L., Kaplan M., et al. | 1995 | AM J ADDICTION | Scopus-id: 2-s2.0-0029016942
| 0 | 10 |
| 167 | Experience with primary biliary cirrhosis in Mexico [Experiencia en México con cirrosis biliar primaria.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 1995 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0029380859
| 0 | 0 |
| 168 | Advances in liver cirrhosis [Los avances en cirrosis hepática.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich Stalnikowitz D. | 1995 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0029380863
| 0 | 0 |
| 169 | Viral hepatitis and alcohol: a synergistic relationship [Hepatitis viral y alcohol: un sinergismo.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 1995 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0029380895
| 0 | 0 |
| 170 | Hepatitis B and liver cancer [Hepatitis B y cáncer de hígado.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 1995 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0029380997
| 0 | 0 |
| 171 | The dopamine d2 receptor gene TaqI a1 polymorphism and alcoholism in a Mexican population | Coautor: Kershenobich D., Cruz C., Camarena B., Mejia J.M., et al. | 1995 | Archives Of Medical Research | Scopus-id: 2-s2.0-0029584646
| 0 | 47 |
| 172 | Non-alcoholic fatty liver: 10 years' experience at the Insituto Nacional de la Nutrición Salvador Zubirán [Esteatohepatitis no alcohólica: Experiencia de 10 años en el Instituto Nacional de la Nutrición Salvador Zubirán.] | Coautor: Kershenobich D., de la Mora G., Olivera M., de la Cerda R., et al. | 1994 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1994NM66600001
Scopus-id: 2-s2.0-0028394383
| 1 | 4 |
| 173 | Alcoholism markers [Marcadores de alcoholismo.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 1994 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0028412678
| 0 | 0 |
| 174 | Alcohol metabolism in healthy subjects | 1ᵉʳ autor: Kershenobich D., Haddad L., Marte L.-J., Vargas F., et al. | 1993 | Gastroenterology | WoS-id: A1993LJ98400045
Scopus-id: 2-s2.0-0027312736
| 0 | 0 |
| 175 | Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies [Prevalencia de anticuerpos antinucleares en cirrosis biliar primaria, con anticuerpos antimitocondriales negativos.] | Coautor: Kershenobich D., Antonio Olivera M., Zapata L., Kaplan M., et al. | 1993 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0027628762
| 0 | 1 |
| 176 | Diarrhea as clinical expression of gastrinoma. A case report [Diarrea como expresión clínica de gastrinoma. Informe de un caso.] | Coautor: Kershenobich D., Meléndez N., Almazán J., Hernández C., et al. | 1993 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0027631625
| 0 | 3 |
| 177 | Clinical characteristics and endoscopic-histologic correlation in patients with chronic non-specific ulcerative colitis [Características clínicas y correlación endoscópico-histológica en pacientes con colitis ulcerosa crónica inespecí | Coautor: Kershenobich D., Sánchez A., Zapata L., Corte G., et al. | 1993 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0027631788
| 0 | 1 |
| 178 | Semiquantitative histologic evaluation of the liver in patients after liver transplantation | Coautor: Kershenobich D., Poo J.L., Hernandez-Pando R., Diliz H., et al. | 1992 | TRANSPLANTATION PROCEEDINGS | WoS-id: A1992JU18000165
Scopus-id: 2-s2.0-0026670549
| 6 | 7 |
| 179 | Pseudomembranous enteritis: Rediscovery of a previously well-described entity? | Coautor: Kershenobich D., Wiesen S., Gregg P.A., Lubin J., et al. | 1992 | AMERICAN JOURNAL OF GASTROENTEROLOGY | WoS-id: A1992JX31900023
Scopus-id: 2-s2.0-0026495564
| 4 | 5 |
| 180 | Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis | Coautor: Kershenobich D., Collawn C., Rubin P., Perez N., et al. | 1992 | AMERICAN JOURNAL OF GASTROENTEROLOGY | WoS-id: A1992HH84200015
Scopus-id: 2-s2.0-0026542531
| 40 | 58 |
| 181 | Liver transplantation in Mexico. Report of the first successful case [Trasplante de hígado en México. Informe del primer caso exitoso.] | Coautor: Kershenobich D., Diliz H., Orozco H., Rodríguez L.C., et al. | 1991 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0025771904
| 0 | 6 |
| 182 | Cytokines and the liver [Citocinas e hígado.] | 1ᵉʳ autor: Kershenobich D., Borovoy J., Guevara L., Male R., et al. | 1990 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1990DU99600006
Scopus-id: 2-s2.0-65249149743
| 0 | 0 |
| 183 | Colchicine: rationale for its use in liver disease [Colchicina. Fundamentos para su uso en enfermedades hepáticas.] | 1ᵉʳ autor: Kershenobich D., Borovoy J., Guevara R.L. | 1990 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1990DU99600022
Scopus-id: 2-s2.0-65249159739
| 0 | 2 |
| 184 | Seroprevalence of viral markers of hepatitis B among health professionals. Multicenter study in Mexico [Seroprevalencia de marcadores virales de hepatitis B en profesionales de la salud. Estudio multicéntrico en México.] | 1ᵉʳ autor: Kershenobich D., Hurtado R., Collawn C., Bobadilla J., et al. | 1990 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1990EU32700001
Scopus-id: 2-s2.0-0025503697
| 12 | 13 |
| 185 | Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis | 1ᵉʳ autor: Kershenobich D., Rojkind M., Quiroga A., Alcocer-Varela J. | 1990 | Hepatology | WoS-id: A1990CR28500007
Scopus-id: 2-s2.0-0025319862
| 46 | 50 |
| 186 | Hepatitis B in Latin America: Epidemiological patterns and eradication strategy | Coautor: Kershenobich D., Fay O.H., Da Costa Gayotto L.C., Da Fonseca J.C.F., et al. | 1990 | Vaccine | WoS-id: A1990DB03700031
Scopus-id: 2-s2.0-0025253037
| 23 | 35 |
| 187 | Colchicine treatment of cirrhosis: answers. | 1ᵉʳ autor: Kershenobich D., Vargas F., Garcia-Tsao G., Tamayo R.P., et al. | 1989 | Hepatology | Scopus-id: 2-s2.0-0024652114
| 0 | 0 |
| 188 | Colchicine in the treatment of cirrhosis | Coautor: Kershenobich D., Fuller R.K., Jones P.K., Schoen R.E., et al. | 1988 | NEW ENGLAND JOURNAL OF MEDICINE | Scopus-id: 2-s2.0-0023790939
| 0 | 2 |
| 189 | Colchicine in the treatment of cirrhosis of the liver | 1ᵉʳ autor: Kershenobich D., Vargas F., Garcia-Tsao G., Perez Tamayo R., et al. | 1988 | NEW ENGLAND JOURNAL OF MEDICINE | WoS-id: A1988N994800002
Scopus-id: 2-s2.0-0023892140
| 306 | 308 |
| 190 | Alcoholic hepatitis [Hepatitis alcohólica.] | Coautor: Kershenobich D., Martín-Abreu L., Guevara L., Alonso de Ruiz P., et al. | 1987 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-0023369959
| 0 | 0 |
| 191 | Low and normal protein diets in chronic uremia: nitrogen and potassium balances and albumin and IgG turnover. | Coautor: Kershenobich D., Peña J.C., Domínguez M., Gaspar J., et al. | 1986 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1986D448600006
Scopus-id: 2-s2.0-0022692904
| 1 | 0 |
| 192 | Antiinflammatory and antifibrogenic activities of colchicine: treatment of liver cirrhosis. | Coautor y autor de correspondencia: Kershenobich D., Rojkind M., Mourelle M. | 1984 | Progress in clinical and biological research | Scopus-id: 2-s2.0-0021158154
| 0 | 14 |
| 193 | Diagnostic procedures for liver fibrosis. | 2ᵒ autor y autor de correspondencia: Kershenobich D., Rojkind M. | 1983 | Laboratory And Research Methods In Biology And Medicine | Scopus-id: 2-s2.0-0020690658
| 0 | 5 |
| 194 | Early detection of alcoholism in a hospital population (author's transl) [Detección precoz de alcoholismo en una población hospitalaria.] | Coautor: Kershenobich D., de la Fuente J.R., Gutiérrez L.M., Rivero F., et al. | 1982 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1982NJ39200001
Scopus-id: 2-s2.0-0020017746
| 15 | 13 |
| 195 | Alcohol and the liver [Alcohol e hígado.] | 1ᵉʳ autor: Kershenobich D., Orillac J. | 1982 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0020155570
| 0 | 1 |
| 196 | Pathophysiology and treatment of fibrosis in liver cirrhosis [FISIOPATOLOGIA Y TRATAMIENTO DE LA FIBROSIS EN LA CIRROSIS HEPATICA] | 2ᵒ autor y autor de correspondencia: Kershenobich D., Rojkind M. | 1982 | GASTROENTEROLOGIA Y HEPATOLOGIA | Scopus-id: 2-s2.0-0020261948
| 0 | 0 |
| 197 | Relationship between blood lactic acid and serum proline in alcoholic liver cirrhosis | 1ᵉʳ autor: Kershenobich D., García-Tsao G., Saldana S.A., Rojkind M. | 1981 | Gastroenterology | WoS-id: A1981LM15300020
Scopus-id: 2-s2.0-0019505642
| 46 | 36 |
| 198 | Hepatic fibrosis | 2ᵒ autor y autor de correspondencia: Kershenobich D., Rojkind M. | 1981 | Clinics In Gastroenterology | WoS-id: A1981MK47700012
Scopus-id: 2-s2.0-0019788085
| 43 | 40 |
| 199 | Cholangitis. Study of 240 patients (author's transl) [Estudio comparativo de 240 casos con colangitis.] | Coautor: Kershenobich D., Alanís J.A., Fainsilber Z., Bornstein M.F. | 1980 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | Scopus-id: 2-s2.0-0019068722
| 0 | 0 |
| 200 | Further evidence for the use of colchicine in the treatment of liver cirrhosis | 1ᵉʳ autor: Kershenobich D., Garcia-Tsao G., Perez Tamayo R., Rojkind M. | 1980 | Gastroenterology | Scopus-id: 2-s2.0-0019130620
| 0 | 0 |
| 201 | Colchicine treatment in advanced chronic active liver disease (CALD) | 1ᵉʳ autor: Kershenobich D., Perez-Tamayo R., Garcia Tsao G., Rojkind M. | 1980 | Gastroenterology | Scopus-id: 2-s2.0-0019165369
| 0 | 1 |
| 202 | Treatment of cirrhosis with colchicine. A double-blind randomized trial | 1ᵉʳ autor: Kershenobich D., Uribe M., Suárez G.I., Mata J.M., et al. | 1979 | Gastroenterology | WoS-id: A1979HG90700018
Scopus-id: 2-s2.0-0018376892
| 133 | 115 |
| 203 | Acute alcoholic hepatitis: clinical, biochemical and liver scintiscanning correlation in assessing prognosis. | Coautor: Kershenobich D., Uribe M., Nieto L., Wolpert E., et al. | 1979 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1979GZ99100005
Scopus-id: 2-s2.0-0018462944
| 1 | 1 |
| 204 | Colchicine, serum albumin, and alkaline phosphatase | 1ᵉʳ autor: Kershenobich D., Uribe M., Suarez G.I., Tamayo R.P., et al. | 1978 | ANNALS OF INTERNAL MEDICINE | WoS-id: A1978FF94200048
Scopus-id: 2-s2.0-0017814431
| 6 | 5 |
| 205 | Endotoxins and liver [Endotoxinas e hígado.] | 1ᵉʳ autor: Kershenobich D., Antonio Alanís J., Fe Bornstein M., Pérez Herrera M., et al. | 1978 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0017867552
| 0 | 0 |
| 206 | Epidemiological aspects of alcoholic liver cirrhosis in Mexico (author's transl) [Consieraciones sobre la epidemiología de la cirrósis hepática alcohólica en México.] | Coautor: Kershenobich D., Dajer F., Guevara L., Arosamena L., et al. | 1978 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1978FF08600002
Scopus-id: 2-s2.0-0017925702
| 8 | 6 |
| 207 | Production of hydrochloric acid, mucus and enzymes [Producción de ácido clorhídrico, moco y enzimas.] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 1976 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0016971293
| 0 | 0 |
| 208 | Hepatic fibrosis. | 2ᵒ autor y autor de correspondencia: Kershenobich D., Rojkind M. | 1976 | Progress In Liver Diseases | Scopus-id: 2-s2.0-0016904459
| 0 | 36 |
| 209 | Treatment of cirrhosis with colchicine: a randomized trial | 1ᵉʳ autor: Kershenobich D., Uribe M., Suarez G.I., Rojkind M. | 1976 | Gastroenterology | Scopus-id: 2-s2.0-0017187591
| 0 | 9 |
| 210 | Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices | 2ᵒ autor y autor de correspondencia: Kershenobich D., Rojkind M. | 1975 | Bba Section Nucleic Acids And Protein Synthesis | WoS-id: A1975V503800010
Scopus-id: 2-s2.0-0016440066
| 104 | 89 |
| 211 | Serum free proline and free hydroxyproline in patients with chronic liver disease | 2ᵒ autor: Kershenobich D., Mata J.M., Villarreal E., Rojkind M. | 1975 | Gastroenterology | WoS-id: A1975AE50600022
Scopus-id: 2-s2.0-0016712233
| 51 | 21 |
| 212 | Primary malignant neoplasms of the duodenum (author's transl) [Tumores malignos primarios del duodeno] | Coautor: Kershenobich D., Quiroz F., Guevara L., Cárdenas S., et al. | 1975 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1975BG76800006
Scopus-id: 2-s2.0-0016563689
| 1 | 0 |
| 213 | Metabolism of immunoglobulins [Metabolismo de las inmunoglobulinas] | 1ᵉʳ autor y autor de correspondencia: Kershenobich D. | 1974 | GACETA MEDICA DE MEXICO | Scopus-id: 2-s2.0-0016056120
| 0 | 0 |
| 214 | TREATMENT OF SCLERODERMA | Coautor: Kershenobich D., Alarcón-Segovia D., IBÁÑEZ G., Rojkind M. | 1974 | Lancet | WoS-id: A1974T132100040
Scopus-id: 2-s2.0-0016159970
| 26 | 16 |
| 215 | Effects of inflammation on iron and transferrin metabolism | 2ᵒ autor: Kershenobich D., O'Shea M.J., Tavill A.S. | 1973 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: A1973R473400003
Scopus-id: 2-s2.0-0015708407
| 41 | 22 |
| 216 | Effect of the administration of l-azetidine-2-carboxylic acid on albumin and transferrin biosynthesis by liver slices of rats treated with carbon tetrachloride | 1ᵉʳ autor: Kershenobich D., Rojkind M. | 1973 | Bba Section Nucleic Acids And Protein Synthesis | WoS-id: A1973Q759900012
Scopus-id: 2-s2.0-0015881498
| 15 | 11 |
| 217 | COLCHICINE AND THE TREATMENT OF LIVER CIRRHOSIS | Coautor y autor de correspondencia: Kershenobich D., Rojkind M., Uribe M. | 1973 | Lancet | WoS-id: A1973O341200028
Scopus-id: 2-s2.0-0015915747
| 69 | 62 |
| 218 | Active chronic liver diseases. Classification and diagnostic criteria [Hepatopatias crónicas activas. Clasificación y criterios diagnósticos.] | 2ᵒ autor: Kershenobich D., Alarcón-Segovia D., Velázquez F., Guevara L. | 1972 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: A1972N737500010
Scopus-id: 2-s2.0-0015362210
| 2 | 1 |
| 219 | Effects of inflammation on iron and transferrin metabolism. | 2ᵒ autor: Kershenobich D., O'Shea M.J., Tavill A.S. | 1971 | BRITISH JOURNAL OF HAEMATOLOGY | WoS-id: A1971K256400021
Scopus-id: 2-s2.0-19244377103
| 0 | 0 |
| 220 | Antacid added to skim milk in the treatment of duodenal ulcer [Antiácido adicionado a leche semidescremada en el tratamineto de la úlcera duodenal.] | 2ᵒ autor: Kershenobich D., Jesús Villalobos J., Ramírez Mata M. | 1970 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | Scopus-id: 2-s2.0-0014774582
| 0 | 1 |
| 221 | The relationship between the free pool of proline and collagen content in human liver cirrhosis. | 1ᵉʳ autor: Kershenobich D., Fierro F.J., Rojkind M. | 1970 | JOURNAL OF CLINICAL INVESTIGATION | WoS-id: A1970H941700012
Scopus-id: 2-s2.0-0014899683
| 104 | 89 |
| 222 | Sleep paralysis [La parálisis del sueño.] | 2ᵒ autor y autor de correspondencia: Kershenobich D., Hernández Peniche J. | 1969 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | Scopus-id: 2-s2.0-0014454335
| 0 | 0 |
ID's SCOPUS